Global Nasal Spray Market expected to reach US$ 40.59 billion by 2033

I had no idea in the beginning that this was such a hotly contested market.

The Global Nasal Spray Market reached US$ 24.16 billion in 2024 and is expected to reach US$ 40.59 billion by 2033, growing at a CAGR of 6.1% during the forecast period 2025-2033. So that gives us a good idea of the space we are in and the demand for products like Nasodine.

In some ways, it looks very much like a race to put the first man on the moon. Since COVID many companies have entered the race, and there are many different idea's on how the perfect product should be formulated and administered. (The way it sprays is a part of the game too!)

It appears that for most of us attempting to get our own fair share of market value, there is a common denominator that we all share. A lack of FDA approvals around the world. At first I thought that was a problem, but apparently not.

Following are the words of another nasal spray producer, trying to achieve the same result as us. (Saving Lives)

"Due to the cumbersome federal regulatory structure, the researchers decided not to seek FDA approval, which can take years, to market the spray as a medical product. Instead, they are selling it as a personal-care product."

"Due to regulations, even though research published in a peer-reviewed journal points toward 99.99% effectiveness, they can't make these claims in their marketing materials."

So it would appear most researchers and producers are all in the same boat. A level playing field, so to speak. We have no disadvantages at all by marketing Nasodine as a personal care product. I initially thought we may, but we don't. FDA would be nice, but not mandatory, as our peers agree.

To quote townsendcalling in his post referencing the Ann: Nasodine to be Launched in Fiji and South Pacific.

@ townsendcalling "You can have all the glossy posters and marketing spin in the world, but word of mouth promotion and face to face interaction is still the most powerful way to do it! Congrats again to Dr Peter!!"

It is quite obvious from here on in. Journal publications, the more the better, peer to peer reviews, communicating with doctors and showcasing our product at platforms like WONCA (World Congress of Family Doctors) conference in Singapore. Do you have trade shows and the like? I don't know, but it would appear that we need to get out their shaking hands and kissing babies so to speak. We need news outlets talking about us, publications talking about us, doctors talking about us, and releasing this into every country we can as a personal care product!

There is a race to market for these types of products; we have the best product, I believe, in Nasodine, and we are in this race.

So lets race!

We don't need to get the full market share; that's impossible. We just need to get our fair share. Once we do, and in years to come, Nasodine will be a well known brand, accepted as being the real deal, the go to product by doctors, hospitals, pharmacists, and the general public.

I am still shocked that the Global Nasal Spray Market is expected to reach US$ 40.59 billion by 2033, as you may be, but if you are on board with FRE, you are in the race. Good luck to all, and here is hoping for continued good news for FRE, Nasodine, and us.